arrow_back Back to App

Independence Investment Fund: Supporting Critical Technologies for US National Security.

This Act establishes the Independence Investment Fund, overseen by the Treasury Department, to invest in US companies developing critical and emerging technologies, particularly biotechnology. The goal is to enhance US national and economic security and protect these companies from adversarial foreign investment. While the fund does not directly impact citizens' personal finances, its success could lead to innovation, new jobs in the technology sector, and greater national economic stability.
Key points
Establishment of the Independence Investment Fund within the US Treasury Department to support the development of critical technologies.
Priority investments in biotechnology and other technologies deemed crucial for national and economic security (e.g., to counter adversarial foreign investment).
The Fund will make equity investments in US-headquartered technology companies, targeting an average investment amount between $1 million and $10 million.
Authorization of $975.5 million for fiscal year 2025 to carry out the Act, including $300 million specifically for biotechnology investments.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_6412
Sponsor: Rep. Sessions, Pete [R-TX-17]
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Independence Investment Fund Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_6412.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What are the main provisions?

Key points include:

  • Establishment of the Independence Investment Fund within the US Treasury Department to support the development of critical technologies.
  • Priority investments in biotechnology and other technologies deemed crucial for national and economic security (e.g., to counter adversarial foreign investment).
  • The Fund will make equity investments in US-headquartered technology companies, targeting an average investment amount between $1 million and $10 million.
  • Authorization of $975.5 million for fiscal year 2025 to carry out the Act, including $300 million specifically for biotechnology investments.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Sessions, Pete [R-TX-17].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Financial Services.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-31.

CATEGORIES

Public Investments Economy Security